Abe, J <br/><br/>
A novel vitamin D3 analog, 22-oxa-1,25-dihydroxyvitamin D3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia.  [electronic resource] 

 -  Endocrinology  Aug 1991 
 - 832-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0013-7227 
<br/><br/><label>Standard No.: </label>10.1210/endo-129-2-832  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Breast Neoplasms--drug therapy<br/>Calcitriol--analogs & derivatives<br/>Calcium--blood<br/>Cell Differentiation--drug effects<br/>Cell Division--drug effects<br/>Doxorubicin--therapeutic use<br/>Humans<br/>Hypercalcemia--chemically induced<br/>Kinetics<br/>Mice<br/>Mice, Nude<br/>Neoplasm Transplantation<br/>Receptors, Estrogen--analysis<br/>Serum Albumin--metabolism<br/>Tumor Cells, Cultured